Some choose off-label drug to treat macular degeneration

09/22/2006 | Miami Herald (free registration), The

While a new drug called Lucentis has been approved by the FDA to restore vision to people with macular degeneration, many doctors are using a similar drug, Avastin, off-label. That's because Avastin costs only about $50 per dose and Lucentis costs about $2,000 per injection.

View Full Article in:

Miami Herald (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL